L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest - PubMed (original) (raw)
L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest
Heinz Läubli et al. Cancer Res. 2006.
Abstract
Hematogenous carcinoma metastasis is supported by aggregated platelets and leukocytes, forming tumor cell emboli. Early tumor cell-platelet interactions can be mediated by P-selectin binding to tumor cell surface ligands and this process is blocked by heparin. We previously showed that L-selectin deficiency also attenuates experimental metastasis. However, the mechanisms and timing of L-selectin action remained unknown. Here, we study how L-selectin facilitates establishment of pulmonary metastatic foci in syngeneic mice by using experimental metastasis to time events following entry of tumor cells into the bloodstream. Although L-selectin deficiency did not affect platelet aggregation or initial tumor cell embolization, the association of leukocytes with tumor cells was reduced and tumor cell survival was diminished 24 hours later. Temporal inhibition of L-selectin by a function-blocking antibody reduced metastasis. Moreover, although selectin blockade by heparin 6 to 18 hours after tumor cell injection was synergistic with P-selectin deficiency in reducing metastasis, there was no further effect in L-selectin-deficient animals. Thus, heparin apparently works at these time points primarily by blocking L-selectin. Endogenous L-selectin ligands were concomitantly induced adjacent to established intravascular tumor cell emboli in a similar time window when leukocytes were also present. Metastasis was attenuated in mice missing these induced endogenous L-selectin ligands due to fucosyltransferase-7 deficiency. Thus, L-selectin facilitation of metastasis progression involves leukocyte-endothelial interactions at sites of intravascular arrest supported by local induction of L-selectin ligands via fucosyltransferase-7. These data provide the first explanation for how leukocyte L-selectin facilitates tumor metastasis.
Similar articles
- Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects.
Stevenson JL, Varki A, Borsig L. Stevenson JL, et al. Thromb Res. 2007;120 Suppl 2:S107-11. doi: 10.1016/S0049-3848(07)70138-X. Thromb Res. 2007. PMID: 18023703 - Expression of L-selectin ligands by transformed endothelial cells enhances T cell-mediated rejection.
Biancone L, Stamenkovic I, Cantaluppi V, Boccellino M, De Martino A, Bussolino F, Camussi G. Biancone L, et al. J Immunol. 1999 May 1;162(9):5263-9. J Immunol. 1999. PMID: 10228001 - Melanoma cell adhesion can be blocked by heparin in vitro: suggestion of VLA-4 as a novel target for antimetastatic approaches.
Fritzsche J, Simonis D, Bendas G. Fritzsche J, et al. Thromb Haemost. 2008 Dec;100(6):1166-75. Thromb Haemost. 2008. PMID: 19132244 - Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans.
Varki NM, Varki A. Varki NM, et al. Semin Thromb Hemost. 2002 Feb;28(1):53-66. doi: 10.1055/s-2002-20564. Semin Thromb Hemost. 2002. PMID: 11885026 Review. - Antimetastatic activities of modified heparins: selectin inhibition by heparin attenuates metastasis.
Borsig L. Borsig L. Semin Thromb Hemost. 2007 Jul;33(5):540-6. doi: 10.1055/s-2007-982086. Semin Thromb Hemost. 2007. PMID: 17629852 Review.
Cited by
- Targeting Selectins and Their Ligands in Cancer.
Natoni A, Macauley MS, O'Dwyer ME. Natoni A, et al. Front Oncol. 2016 Apr 18;6:93. doi: 10.3389/fonc.2016.00093. eCollection 2016. Front Oncol. 2016. PMID: 27148485 Free PMC article. Review. - Extravasation of leukocytes in comparison to tumor cells.
Strell C, Entschladen F. Strell C, et al. Cell Commun Signal. 2008 Dec 4;6:10. doi: 10.1186/1478-811X-6-10. Cell Commun Signal. 2008. PMID: 19055814 Free PMC article. - Circulating tumor cells clusters and their role in Breast cancer metastasis; a review of literature.
Sayed ZS, Khattap MG, Madkour MA, Yasen NS, Elbary HA, Elsayed RA, Abdelkawy DA, Wadan AS, Omar I, Nafady MH. Sayed ZS, et al. Discov Oncol. 2024 Apr 1;15(1):94. doi: 10.1007/s12672-024-00949-7. Discov Oncol. 2024. PMID: 38557916 Free PMC article. Review. - Selectins in cancer immunity.
Borsig L. Borsig L. Glycobiology. 2018 Sep 1;28(9):648-655. doi: 10.1093/glycob/cwx105. Glycobiology. 2018. PMID: 29272415 Free PMC article. Review. - Prominent Role of Histone Modifications in the Regulation of Tumor Metastasis.
Markouli M, Strepkos D, Basdra EK, Papavassiliou AG, Piperi C. Markouli M, et al. Int J Mol Sci. 2021 Mar 9;22(5):2778. doi: 10.3390/ijms22052778. Int J Mol Sci. 2021. PMID: 33803458 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases